CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 30 target
Drug / intervention
MRIother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03582189
NCT03582189N/ARecruitingOn TrackUpdated 3mo ago
Long Recruiting

A Feasibility Study of Magnetic Resonance Imaging (MRI) as a Platform for Image Guidance and Adaptive Radiation Therapy in Patients With Liver or Pancreatic Cancer

University Health Network, Toronto·observational·Posted Jul 10, 2018·Updated Mar 5, 2026

In Brief

An observational study evaluating MRI for Magnetic Resonance Imaging. Currently recruiting, targeting 30 participants across 1 site.

Detailed Summary

This is a single centre, single arm, prospective feasibility study that aims to see whether magnetic resonance imaging (MRI) as a source of image guidance before each radiation treatment fraction is feasible, and also if it may provide information that could potentially be used during the treatment to improve the radiation treatment plan. Patients will have 5 MRIs with each of their RT sessions. If patients' RT treatment will consist of more than 5 fractions, only 5 MRIs will be done with any 5 RT fractions. Patients will be completing a short questionnaire at the end of each MRI. A patient questionnaire will also be completed at the end of the study to assess for patient satisfaction. There will be 30 evaluable patients enrolled to the study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ARecruiting
201920202021202220232024202520262027
First PostedJul 10, 2018
Enrollment StartJul 11, 2018
Primary CompletionFeb 1, 2027
TodayJul 2, 2026
Enrollment to primary: 8.6 yearsPosted 8.0 years agoPrimary completion in 7 months

Interventions

MRIother

Patients who consent to this study will have an abdominal MRI prior to or immediately after each fraction of radiation treatment in the case of those patients that are undergoing SBRT or those receiving palliative treatment. On patients receiving definitive chemoradiation, an abdominal MRI will be performed prior to or immediately after radiation treatment once per week during the any five weeks of treatment